Past investments

• ENYO Pharma
• Y-mAbs Therapeutics
• NuCana
• Histogenics
• Amplyx Pharmaceuticals
• Sorbent Therapeutics
• Visen Pharmaceuticals
• Versartis
• Auris Medical
• Aerovate Therapeutics
• Medeor Therapeutics
• Guavus
• Edge Therapeutics
• NorthSea Therapeutics
• Athira Pharma
• Ascendis Pharma
• Audentes Therapeutics
• CinCor Pharma
• Karuna Therapeutics
• Bolt Biotherapeutics
• Vestagen Technical Textiles
• InCarda Therapeutics
• Ziarco
• Pionyr Immunotherapeutics
• Invitae
• AFYX Therapeutics
• XyloCor Therapeutics
• Natera
• LYSOGENE
• Neurana Pharmaceuticals
• Kiniksa Pharmaceuticals
• Aeovian Pharmaceuticals
• Principia Biopharma
• Innocoll Holdings
• Quanta Therapeutics
• NuCana BioMed
• ZS Pharma
• NextCure
• ConteXtream
• Chiasma
• Aclaris Therapeutics
• Vera Therapeutics
• Checkmate Pharmaceuticals
• First Aid Shot Therapy
• Apellis Pharmaceuticals
• McPhy
• Civitas Therapeutics
• Crocus Technology
• Atsena Therapeutics
• Rainier Therapeutics
• Galera Therapeutics
• Gyroscope Therapeutics
• VelosBio
• Antiva Biosciences
• Intrepida Bio
• Merus
• Mirna Therapeutics
• Akouos
• Coherus Biosciences
• aTyr Pharma
• Inozyme
• Promedior
• Iterum Therapeutics
• ObsEva
• Dauntless Pharmaceuticals
• Spark Therapeutics
• Entasis Therapeutics